A database of RNA aptamers
Example: RNA aptamer SELEX ATP-aptamer Structure
Statistical information
A statistical analysis has been conducted on the structural determination and phase elucidation of RNA aptamers. Upper left figure: A statistical summary of structural elucidation methods for RNA aptamers, including X-ray crystallography, nuclear magnetic resonance (NMR) spectroscopy, and cryo-electron microscopy (cryo-EM). Upper right figure: A statistical summary of solutions to phase problems generated by X-ray structural elucidation, such as Molecular Replacement (MR). Lower left figure: A statistical summary of phase problem solutions for aptamers targeting small molecules. Lower right figure: A statistical summary of phase problem solutions for aptamers targeting proteins and nucleic acids.
Detailed information
This section displaysCategory | Name | Ligand | Structure Determination | NDB | Phase Determination | Resolution(Å) | Year |
---|---|---|---|---|---|---|---|
Biologics & Signaling Molecules | FMN aptamer | FMN | NMR | 1FMN | NA | NA | 1996 |
Amino Acids & Peptides | Arginine aptamer | Arginine | NMR | 1KOC | NA | NA | 1996 |
Amino Acids & Peptides | Citrulline aptamer | Citrulline | NMR | 1KOD | NA | NA | 1996 |
Biologics & Signaling Molecules | Vitamin B12-aptamer | Vitamin B12 | X-ray | 1ET4 1DDY |
molecular replacement(MR), Co(MAD) |
2.3 >3.0 |
2000a 2000b |
Biologics & Signaling Molecules | Biotin aptamer | Biotin | X-ray | 1F27 | Se (MAD) | 1.3 | 2000 |
Biologics & Signaling Molecules | 5HTP-aptamer | 5-HT | X-ray | 5KPY | Ir (SIRAS) | 2.0 | 2017 |
Biologics & Signaling Molecules | Riboflavin aptamer | FMN | NMR | 7RWR | NA | NA | 2022 |
Pharmaceuticals | Theophylline-aptamer | TAL3 theophylline apo TAL2 TAL1 TAL4 |
X-ray | 8D2A 8D28 8D29 8D2B 8D5L 8D5O |
molecular replacement(MR) | 2.17 1.42 1.81 1.44 1.64 2.7 |
2022 |
Fluorophores | MG aptamer | tetramethylrosamine(TMR) malachite green |
X-ray | 1F1T | Br (MAD) | 2.8 | 2000 |
NMR | 1Q8N | NA | NA | 2004 | |||
Fluorophores | Spinach aptamer | DFHBI-1T DFHBI DFHBI trifluoroethyl, Fab 1TU, Fab bromo-ligand analog, Fab |
X-ray | 4TS0 4TS2 5OB3 4Q9R 4KZD 4Q9Q |
Ba (SAD), molecular replacement(MR) |
2.8 2.88 2.0 3.12 2.19 2.45 |
2014a 2014b 2017 |
Fluorophores | GTP aptamer | GTP | NMR | 5LWJ 2AU4 |
NA | NA | 2006 2017 |
Fluorophores | Corn aptamer | DFHO DFHO ThT ThT TO apo |
X-ray | 5BJP 5BJO 6E81 6E82 6E84 6E80 |
Ir (SAD), molecular replacement(MR) |
2.51 2.35 2.721 3.1 2.9 2.9 |
2017 2019 |
Fluorophores | Mango aptamer(TO1-biotin) | TO1-Biotin TO1-Biotin TO3-Biotin TO1-Biotin TO1-Biotin TO1-Biotin |
X-ray | 5V3F 6C63 6C64 6C65 6V9B 6V9D |
Ir (SAD), molecular replacement(MR) |
1.7 2.9 3.0 2.8 2.4 2.8 |
2017 2018 2020 |
Fluorophores | DIR2s-apt aptamer | oxazole thiazole blue (OTB) | X-ray | 6DB9 6DB8 |
molecular replacement(MR) | 2.025 | 2018 |
Fluorophores | Mango-III aptamer(YO3) | TO1-Biotin TO1-Biotin TO1-Biotin TO1-Biotin YO3-Biotin DFHBI-1T |
X-ray | 6E8S 6E8T 6E8U 6PQ7 6UP0 7L0Z |
Ir(SAD), molecular replacement(MR) |
2.35 2.9 1.55 3.0 2.8 2.1 |
2019a 2019b 2021 |
Fluorophores | TMR aptamer | tetramethylrhodamine | NMR | 6GZR 6GZK |
NA | NA | 2020 |
Fluorophores | Chili aptamer | DMHBI+ DMHBO+ DMHBO+ DMHBO+ |
X-ray | 7OAW 7OA3 7OAV 7OAX |
molecular replacement(MR), Ir (SAD) |
2.95 2.8 2.99 2.24 |
2021 |
Fluorophores | Pepper aptamer | HBC HBC HBC HBC HBC485 HBC497 HBC508 HBC514 HBC525 HBC620 HBC599 and Fab BL3-6 HBC and Fab BL3-6 |
X-ray | 7EOH 7EOG 7EOI 7EOJ 7EOK 7EOL 7EOM 7EON 7EOO 7EOP 7U0Y 7SZU |
Ir (SAD), molecular replacement(MR) |
1.64 1.5 1.92 1.77 2.7 2.31 2.7 2.3 2.23 1.8 2.66 2.24 |
2021 2022 |
Fluorophores | Squash aptamer | DFHBI-1T | X-ray | 7KVT 7KVU 7KVV |
Ir (SAD), molecular replacement(MR) |
2.73 2.68 2.85 |
2022 |
Fluorophores | Beetroot aptamer | DFAME ThT DFHO DFHO |
X-ray | 8EYU 8EYW 8F0N 8EYV |
molecular replacement(MR) | 1.95 2.1 2.85 2.55 |
2023 |
Nucleosides & Nucleotides | AMP aptamer | AMP | NMR | 1AM0 1RAW |
NA | NA | 1996a 1996b |
Nucleosides & Nucleotides | ATP aptamer | AMPNAapo | EM | 6WLJ 6WLK |
NA | 9.6 | 2020 |
Pharmaceuticals | Tobramycin-RNA aptamer | Aminoglycoside tobramycin |
NMR | 1TOB 2TOB |
NA | NA | 1997 1998 |
Pharmaceuticals | Theophylline-aptamer | theophylline | NMR | 1EHT 1O15 |
NA | NA | 1997 2003 |
Pharmaceuticals | NeomycinB RNA aptamer | neomycin B | NMR | 1NEM | NA | NA | 1999 |
Pharmaceuticals | Streptomycin-RNA Aptamer | Streptomycin | X-ray | 1NTA 1NTB |
Ba (MAD) | 2.9 | 2003 |
Pharmaceuticals | Tetracycline aptamer | tetracycline | X-ray | 3EGZ | Se (MAD) | 2.2 | 2008 |
Category | Name | Ligand | Structure Determination | NDB | Phase Determination | Resolution(Å) | Year |
---|---|---|---|---|---|---|---|
Bacteria | Hfq aptamer | YmaH (Hfq) | X-ray | 3HSB 3AHU |
molecular replacement(MR) | 2.2 | 2012 |
Bacteria | Ribosomal protein S8-aptamer | ribosomal protein S8 | X-ray | 4PDB | molecular replacement(MR) | 2.6 | 2014a |
NMR | 2LUN | NA | NA | 2014b | |||
Bacteria | TetR aptamer | transcription repressor TetR | X-ray | 6SY4 6SY6 |
molecular replacement(MR) | 2.69 2.9 |
2020 |
Mammalian | GlnRs aptamer | GlnRS Gln |
X-ray | 1EXD | molecular replacement(MR) | 2.7 | 2000 |
Mammalian | NF-kappaB aptamer | NF-kappaB | X-ray | 1OOA | molecular replacement(MR) and single isomorphous replacement (SIR) methods | 2.45 | 2003 |
NMR | 2JWV | NA | NA | 2008 | |||
Mammalian | (eIF4A)-aptamer | initiation factor 4A (eIF4A) | NMR | 1XWP 1XWU |
NA | NA | 2005 |
Mammalian | FC RNA aptamer | RNA polymerase (Pol) II | X-ray | 2B63 | Br (SAD) | 3.8 | 2005 |
Mammalian | Thrombin aptamer | human thrombin | X-ray | 3DD2 | molecular replacement(MR) | 1.9 | 2008 |
Mammalian | IgG aptamer | human IgG | X-ray | 3AGV | molecular replacement(MR) | 2.15 | 2010 |
Mammalian | GRK2 aptamer | G protein-coupled receptor kinase 2 (GRK2) | X-ray | 3UZT 3UZS |
molecular replacement(MR) | 3.51 | 2012 |
Mammalian | lysozyme aptamer | lysozyme | X-ray | 4M6D 4M4O |
molecular replacement(MR) | 2.68 2.0 |
2013 |
Mammalian | NOX-E36 L-aptamer | L-CLL2 | X-ray | 4R8I | Se (SAD) | 2.05 | 2015 |
Mammalian | Thrombin aptamer | Thrombin | X-ray | 5DO4 | molecular replacement(MR) | 1.86 | 2016 |
Mammalian | Factor Xa-aptamer | factor Xa (FXa) factor Xa and Rivaroxaban |
X-ray | 5VOE 5VOF |
molecular replacement(MR) | 2.0 2.25 |
2018 |
Mammalian | Spinach RNA aptamer | Fab BL3-6S97N | X-ray | 6B14 6B3K |
molecular replacement(MR) | 1.64 2.09 |
2018 |
Mammalian | A9g RNA aptamer | human glutamate carboxypeptidase II (GCPII) | X-ray | 6RTI | molecular replacement(MR) | 2.2 | 2020 |
Others | Bacteriophage MS2 coat protein-aptamer | bacteriophage MS2 coat protein | X-ray | 6MSF 5MSF,7MSF 1U1Y |
molecular replacement(MR) | 2.8 2.8 2.85 |
1998a 1998b 2004 |
Others | Bovine prion protein(bPrP) aptamer | prion | NMR | 2RQJ 2RSK 2RU7 6K84 |
NA | NA | 2009 2013 2014 2020 |
Viral | HIV-1 REV peptide-aptamer | REV peptide | NMR | 1ULL 484D |
NA | NA | 1996 1999 |
Viral | REX16 aptamer | HTLV-1 arginine-rich Rex peptide | NMR | 1EXY | NA | NA | 2000 |
Viral | Tat aptamer | HIV Tat protein | NMR | 1NBK | NA | NA | 2003 |
Fluorophores | Spinach aptamer | Trifluoroethyl, Fab 1TU, Fab bromo-ligand analog, Fab Fab |
X-ray | 4Q9R 4KZD 4Q9Q 4KZE |
molecular replacement(MR) | 3.12 2.19 2.45 2.4 |
2014 |
Category | Name | Ligand | Structure Determination | NDB | Phase Determination | Resolution(Å) | Year |
---|---|---|---|---|---|---|---|
Mammalian | AML1 (RUNX1)-aptamer | AML1 Runt domain | NMR | 2RRC | NA | NA | 2011 |
Viral | LR06(GA) aptamer | TAR RNA | NMR | 2OOM 2PN9 |
NA | NA | 2007 |
NMR | 2RN1 | NA | NA | 2008a | |||
X-ray | 2JLT | Br(SAD) | 2.9 | 2008b | |||
Viral | RBA-14 aptamer | Rev RNA | X-ray | 6CF2 | molecular replacement(MR) | 3.0 | 2018 |